TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment August 26, 1988
TCL Archive Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86 February 6, 1987
